aluates Reports

$ 0.0

Automative

Global HAE Treatments Market Research Report 2026

Published Date: 2026-02-10

Report Code: QYRE-Auto-5H18377

Global HAE Treatments Market Research Report 2024

BUY CHAPTERS

Global HAE Treatments Market Research Report 2026

Code: QYRE-Auto-5H18377

Report

2026-02-10

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda Pharmaceuticals

BioCryst Pharmaceuticals

CSL Behring

Pharming Healthcare

HAE Treatments Market

The global HAE Treatments market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on HAE Treatments competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

HAE (Hereditary Angioedema) treatments aim to manage and prevent the unpredictable and potentially life-threatening swelling episodes associated with the condition. These treatments target the underlying cause: a deficiency or dysfunction of C1 esterase inhibitor (C1-INH), which leads to uncontrolled activation of the complement and kallikrein-kinin systems, resulting in swelling. There are three main categories of HAE treatments: C1-INH replacement therapies (e.g., Berinert, Haegarda) that restore functional C1-INH levels; kallikrein inhibitors (e.g., Ecallantide) that block the enzyme responsible for bradykinin production; and bradykinin B2 receptor antagonists (e.g., Icatibant) that prevent bradykinin from causing vascular permeability and swelling.

The North American market for HAE Treatments is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for HAE Treatments is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of HAE Treatments include Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global HAE Treatments market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding HAE Treatments. The HAE Treatments market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global HAE Treatments market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist HAE Treatments manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of HAE Treatments Market Report

Report Metric	Details
Report Name	HAE Treatments Market
Segment by Type	C1 Esterase Inhibitors Kallikrein Inhibitors Bradykinin Receptor Antagonist
by Application	Hospital and Clinic Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for HAE Treatments manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines HAE Treatments sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the HAE Treatments Market report?

Ans: The main players in the HAE Treatments Market are Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare

What are the Application segmentation covered in the HAE Treatments Market report?

Ans: The Applications covered in the HAE Treatments Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the HAE Treatments Market report?

Ans: The Types covered in the HAE Treatments Market report are C1 Esterase Inhibitors, Kallikrein Inhibitors, Bradykinin Receptor Antagonist

1 HAE Treatments Market Overview

1.1 Product Definition

1.2 HAE Treatments by Type

1.2.1 Global HAE Treatments Market Value by Type: 2025 vs 2032

1.2.2 C1 Esterase Inhibitors

1.2.3 Kallikrein Inhibitors

1.2.4 Bradykinin Receptor Antagonist

1.3 HAE Treatments by Application

1.3.1 Global HAE Treatments Market Value by Application: 2025 vs 2032

1.3.2 Hospital and Clinic

1.3.3 Pharmacy

1.3.4 Other

1.4 Global HAE Treatments Market Size Estimates and Forecasts

1.4.1 Global HAE Treatments Revenue 2021–2032

1.4.2 Global HAE Treatments Sales 2021–2032

1.4.3 Global HAE Treatments Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 HAE Treatments Market Competition by Manufacturers

2.1 Global HAE Treatments Sales Market Share by Manufacturers (2021–2026)

2.2 Global HAE Treatments Revenue Market Share by Manufacturers (2021–2026)

2.3 Global HAE Treatments Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of HAE Treatments, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of HAE Treatments, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of HAE Treatments, Product Types and Applications

2.7 Global Key Manufacturers of HAE Treatments, Date of Entry into the Industry

2.8 Global HAE Treatments Market Competitive Situation and Trends

2.8.1 Global HAE Treatments Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global HAE Treatments Players Market Share by Revenue

2.8.3 Global HAE Treatments Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global HAE Treatments Market Scenario by Region

3.1 Global HAE Treatments Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global HAE Treatments Sales by Region: 2021–2032

3.2.1 Global HAE Treatments Sales by Region: 2021–2026

3.2.2 Global HAE Treatments Sales by Region: 2027–2032

3.3 Global HAE Treatments Revenue by Region: 2021–2032

3.3.1 Global HAE Treatments Revenue by Region: 2021–2026

3.3.2 Global HAE Treatments Revenue by Region: 2027–2032

3.4 North America HAE Treatments Market Facts & Figures by Country

3.4.1 North America HAE Treatments Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America HAE Treatments Sales by Country (2021–2032)

3.4.3 North America HAE Treatments Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe HAE Treatments Market Facts & Figures by Country

3.5.1 Europe HAE Treatments Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe HAE Treatments Sales by Country (2021–2032)

3.5.3 Europe HAE Treatments Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific HAE Treatments Market Facts & Figures by Region

3.6.1 Asia Pacific HAE Treatments Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific HAE Treatments Sales by Region (2021–2032)

3.6.3 Asia Pacific HAE Treatments Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America HAE Treatments Market Facts & Figures by Country

3.7.1 Latin America HAE Treatments Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America HAE Treatments Sales by Country (2021–2032)

3.7.3 Latin America HAE Treatments Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa HAE Treatments Market Facts & Figures by Country

3.8.1 Middle East and Africa HAE Treatments Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa HAE Treatments Sales by Country (2021–2032)

3.8.3 Middle East and Africa HAE Treatments Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global HAE Treatments Sales by Type (2021–2032)

4.1.1 Global HAE Treatments Sales by Type (2021–2026)

4.1.2 Global HAE Treatments Sales by Type (2027–2032)

4.1.3 Global HAE Treatments Sales Market Share by Type (2021–2032)

4.2 Global HAE Treatments Revenue by Type (2021–2032)

4.2.1 Global HAE Treatments Revenue by Type (2021–2026)

4.2.2 Global HAE Treatments Revenue by Type (2027–2032)

4.2.3 Global HAE Treatments Revenue Market Share by Type (2021–2032)

4.3 Global HAE Treatments Price by Type (2021–2032)

5 Segment by Application

5.1 Global HAE Treatments Sales by Application (2021–2032)

5.1.1 Global HAE Treatments Sales by Application (2021–2026)

5.1.2 Global HAE Treatments Sales by Application (2027–2032)

5.1.3 Global HAE Treatments Sales Market Share by Application (2021–2032)

5.2 Global HAE Treatments Revenue by Application (2021–2032)

5.2.1 Global HAE Treatments Revenue by Application (2021–2026)

5.2.2 Global HAE Treatments Revenue by Application (2027–2032)

5.2.3 Global HAE Treatments Revenue Market Share by Application (2021–2032)

5.3 Global HAE Treatments Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Takeda Pharmaceuticals

6.1.1 Takeda Pharmaceuticals Company Information

6.1.2 Takeda Pharmaceuticals Description and Business Overview

6.1.3 Takeda Pharmaceuticals HAE Treatments Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Takeda Pharmaceuticals HAE Treatments Product Portfolio

6.1.5 Takeda Pharmaceuticals Recent Developments/Updates

6.2 BioCryst Pharmaceuticals

6.2.1 BioCryst Pharmaceuticals Company Information

6.2.2 BioCryst Pharmaceuticals Description and Business Overview

6.2.3 BioCryst Pharmaceuticals HAE Treatments Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 BioCryst Pharmaceuticals HAE Treatments Product Portfolio

6.2.5 BioCryst Pharmaceuticals Recent Developments/Updates

6.3 CSL Behring

6.3.1 CSL Behring Company Information

6.3.2 CSL Behring Description and Business Overview

6.3.3 CSL Behring HAE Treatments Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 CSL Behring HAE Treatments Product Portfolio

6.3.5 CSL Behring Recent Developments/Updates

6.4 Pharming Healthcare

6.4.1 Pharming Healthcare Company Information

6.4.2 Pharming Healthcare Description and Business Overview

6.4.3 Pharming Healthcare HAE Treatments Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Pharming Healthcare HAE Treatments Product Portfolio

6.4.5 Pharming Healthcare Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 HAE Treatments Industry Chain Analysis

7.2 HAE Treatments Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 HAE Treatments Production Mode & Process Analysis

7.4 HAE Treatments Sales and Marketing

7.4.1 HAE Treatments Sales Channels

7.4.2 HAE Treatments Distributors

7.5 HAE Treatments Customer Analysis

8 HAE Treatments Market Dynamics

8.1 HAE Treatments Industry Trends

8.2 HAE Treatments Market Drivers

8.3 HAE Treatments Market Challenges

8.4 HAE Treatments Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceuticals

BioCryst Pharmaceuticals

CSL Behring

Pharming Healthcare

List of Tables

Table 1. Global HAE Treatments Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global HAE Treatments Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global HAE Treatments Market Competitive Situation by Manufacturers in 2025

Table 4. Global HAE Treatments Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global HAE Treatments Sales Market Share by Manufacturers (2021–2026)

Table 6. Global HAE Treatments Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global HAE Treatments Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market HAE Treatments Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of HAE Treatments, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of HAE Treatments, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of HAE Treatments, Product Types and Applications

Table 12. Global Key Manufacturers of HAE Treatments, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global HAE Treatments Companies by Tier (Tier 1, Tier 2, Tier 3), based on HAE Treatments Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global HAE Treatments Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global HAE Treatments Sales by Region (K Units), 2021–2026

Table 18. Global HAE Treatments Sales Market Share by Region (2021–2026)

Table 19. Global HAE Treatments Sales by Region (K Units), 2027–2032

Table 20. Global HAE Treatments Sales Market Share by Region (2027–2032)

Table 21. Global HAE Treatments Revenue by Region (US$ Million), 2021–2026

Table 22. Global HAE Treatments Revenue Market Share by Region (2021–2026)

Table 23. Global HAE Treatments Revenue by Region (US$ Million), 2027–2032

Table 24. Global HAE Treatments Revenue Market Share by Region (2027–2032)

Table 25. North America HAE Treatments Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America HAE Treatments Sales by Country (K Units), 2021–2026

Table 27. North America HAE Treatments Sales by Country (K Units), 2027–2032

Table 28. North America HAE Treatments Revenue by Country (US$ Million), 2021–2026

Table 29. North America HAE Treatments Revenue by Country (US$ Million), 2027–2032

Table 30. Europe HAE Treatments Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe HAE Treatments Sales by Country (K Units), 2021–2026

Table 32. Europe HAE Treatments Sales by Country (K Units), 2027–2032

Table 33. Europe HAE Treatments Revenue by Country (US$ Million), 2021–2026

Table 34. Europe HAE Treatments Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific HAE Treatments Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific HAE Treatments Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific HAE Treatments Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific HAE Treatments Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific HAE Treatments Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America HAE Treatments Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America HAE Treatments Sales by Country (K Units), 2021–2026

Table 42. Latin America HAE Treatments Sales by Country (K Units), 2027–2032

Table 43. Latin America HAE Treatments Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America HAE Treatments Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa HAE Treatments Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa HAE Treatments Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa HAE Treatments Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa HAE Treatments Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa HAE Treatments Revenue by Country (US$ Million), 2027–2032

Table 50. Global HAE Treatments Sales (K Units) by Type (2021–2026)

Table 51. Global HAE Treatments Sales (K Units) by Type (2027–2032)

Table 52. Global HAE Treatments Sales Market Share by Type (2021–2026)

Table 53. Global HAE Treatments Sales Market Share by Type (2027–2032)

Table 54. Global HAE Treatments Revenue (US$ Million) by Type (2021–2026)

Table 55. Global HAE Treatments Revenue (US$ Million) by Type (2027–2032)

Table 56. Global HAE Treatments Revenue Market Share by Type (2021–2026)

Table 57. Global HAE Treatments Revenue Market Share by Type (2027–2032)

Table 58. Global HAE Treatments Price (US$/Unit) by Type (2021–2026)

Table 59. Global HAE Treatments Price (US$/Unit) by Type (2027–2032)

Table 60. Global HAE Treatments Sales (K Units) by Application (2021–2026)

Table 61. Global HAE Treatments Sales (K Units) by Application (2027–2032)

Table 62. Global HAE Treatments Sales Market Share by Application (2021–2026)

Table 63. Global HAE Treatments Sales Market Share by Application (2027–2032)

Table 64. Global HAE Treatments Revenue (US$ Million) by Application (2021–2026)

Table 65. Global HAE Treatments Revenue (US$ Million) by Application (2027–2032)

Table 66. Global HAE Treatments Revenue Market Share by Application (2021–2026)

Table 67. Global HAE Treatments Revenue Market Share by Application (2027–2032)

Table 68. Global HAE Treatments Price (US$/Unit) by Application (2021–2026)

Table 69. Global HAE Treatments Price (US$/Unit) by Application (2027–2032)

Table 70. Takeda Pharmaceuticals Company Information

Table 71. Takeda Pharmaceuticals Description and Business Overview

Table 72. Takeda Pharmaceuticals HAE Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Takeda Pharmaceuticals HAE Treatments Product

Table 74. Takeda Pharmaceuticals Recent Developments/Updates

Table 75. BioCryst Pharmaceuticals Company Information

Table 76. BioCryst Pharmaceuticals Description and Business Overview

Table 77. BioCryst Pharmaceuticals HAE Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. BioCryst Pharmaceuticals HAE Treatments Product

Table 79. BioCryst Pharmaceuticals Recent Developments/Updates

Table 80. CSL Behring Company Information

Table 81. CSL Behring Description and Business Overview

Table 82. CSL Behring HAE Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. CSL Behring HAE Treatments Product

Table 84. CSL Behring Recent Developments/Updates

Table 85. Pharming Healthcare Company Information

Table 86. Pharming Healthcare Description and Business Overview

Table 87. Pharming Healthcare HAE Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Pharming Healthcare HAE Treatments Product

Table 89. Pharming Healthcare Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. HAE Treatments Distributors List

Table 93. HAE Treatments Customers List

Table 94. HAE Treatments Market Trends

Table 95. HAE Treatments Market Drivers

Table 96. HAE Treatments Market Challenges

Table 97. HAE Treatments Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of HAE Treatments

Figure 2. Global HAE Treatments Market Value by Type (US$ Million), 2021–2032

Figure 3. Global HAE Treatments Market Share by Type: 2025 & 2032

Figure 4. C1 Esterase Inhibitors Product Picture

Figure 5. Kallikrein Inhibitors Product Picture

Figure 6. Bradykinin Receptor Antagonist Product Picture

Figure 7. Global HAE Treatments Market Value by Application (US$ Million), 2021–2032

Figure 8. Global HAE Treatments Market Share by Application: 2025 & 2032

Figure 9. Hospital and Clinic

Figure 10. Pharmacy

Figure 11. Other

Figure 12. Global HAE Treatments Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global HAE Treatments Market Size (US$ Million), 2021–2032

Figure 14. Global HAE Treatments Sales (K Units), 2021–2032

Figure 15. Global HAE Treatments Average Price (US$/Unit), 2021–2032

Figure 16. HAE Treatments Report Years Considered

Figure 17. HAE Treatments Sales Share by Manufacturers in 2025

Figure 18. Global HAE Treatments Revenue Share by Manufacturers in 2025

Figure 19. Top 5 and Top 10 Global HAE Treatments Players: Market Share by Revenue in HAE Treatments in 2025

Figure 20. HAE Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Global HAE Treatments Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 22. North America HAE Treatments Sales Market Share by Country (2021–2032)

Figure 23. North America HAE Treatments Revenue Market Share by Country (2021–2032)

Figure 24. United States HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Canada HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Europe HAE Treatments Sales Market Share by Country (2021–2032)

Figure 27. Europe HAE Treatments Revenue Market Share by Country (2021–2032)

Figure 28. Germany HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. France HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. U.K. HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Italy HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Russia HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Asia Pacific HAE Treatments Sales Market Share by Region (2021–2032)

Figure 34. Asia Pacific HAE Treatments Revenue Market Share by Region (2021–2032)

Figure 35. China HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Japan HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. South Korea HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. India HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Australia HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. China Taiwan HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Southeast Asia HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Latin America HAE Treatments Sales Market Share by Country (2021–2032)

Figure 43. Latin America HAE Treatments Revenue Market Share by Country (2021–2032)

Figure 44. Mexico HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Brazil HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Argentina HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Colombia HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Middle East and Africa HAE Treatments Sales Market Share by Country (2021–2032)

Figure 49. Middle East and Africa HAE Treatments Revenue Market Share by Country (2021–2032)

Figure 50. Turkey HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Saudi Arabia HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. UAE HAE Treatments Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Global Sales Market Share of HAE Treatments by Type (2021–2032)

Figure 54. Global Revenue Market Share of HAE Treatments by Type (2021–2032)

Figure 55. Global HAE Treatments Price (US$/Unit) by Type (2021–2032)

Figure 56. Global Sales Market Share of HAE Treatments by Application (2021–2032)

Figure 57. Global Revenue Market Share of HAE Treatments by Application (2021–2032)

Figure 58. Global HAE Treatments Price (US$/Unit) by Application (2021–2032)

Figure 59. HAE Treatments Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Hereditary Angioedema Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global C1 INH Replacement Therapy Market Research Report 2024

Global Icatibant Acetate Injection Market Research Report 2024

Global Icatibant Acetate API Market Research Report 2024

Global Hereditary Angioedema Therapeutic Market Insights Forecast to 2030

C1 Esterase Inhibitor Subcutaneous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Icatibant Acetate Market Research Report 2024

Global Hereditary Angioedema Treatment Market Insights Forecast to 2030

Global Icatibatide Acetate Market Research Report 2024

Global Bradykinin Receptor Antagonists Market Research Report 2024

Global Kallikrein Inhibitors Market Research Report 2024

C1 Esterase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Complement Inhibitors Market Research Report 2024

Global C1 Esterase Inhibitors Market Research Report 2024

Global Treatment of PNH Market Research Report 2024

Global Angioedema Treatment Market Insights Forecast to 2030

Global Non infectious Macular Edema Treatment Market Insights Forecast to 2030

Global Complement Protein C3 Inhibitors Market Research Report 2024

Global Treatment of Congenital Adrenal Hyperplasia Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions